FeesSafety
Pluang+

Eight uranium targets identified at Fontaine Lake project, boosting exploration potential in Saskatchewan.

Market News
03 Nov 2026, 14:00 WIB
TheNewswire
View Source
Bullish
Eight uranium targets identified at Fontaine Lake project, boosting exploration potential in Saskatchewan.

Global Energy Metals highlights the discovery of eight high-priority uranium targets at the Fontaine Lake project in Saskatchewan, following an airborne geophysical survey by Terra North Resources. This progress supports the company's 0.5% NSR royalty exposure across 594 km² of uranium properties, including Fontaine Lake and Charlot-Neely Lake. The findings, which include uranium grades up to 1.44% U₃O₈ and associations with the Grease River Shear Zone, reinforce the region's exploration potential. Global Energy Metals benefits from these advances without direct exploration costs, aligning with its strategy to hold strategic royalties in critical minerals for long-term value.

Global Energy Metals' uranium exploration progress is noted alongside Basic Materials sector data from Pluang. For readers following Basic Materials stocks, here is Pluang's market snapshot as of Nov 03, 2026 19:12 WIB: out of 83 priced US stocks, 20 rose and 59 fell. Notable movers include USAS at USD 2.81 with a 1-day change of -2.43% and a typical hold time of 5 days, CRH at USD 94.40 down 2.27%, and IAG at USD 15.64 down 2.25%.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App